A groundbreaking shift in our drug policy has taken place, as the regulators announce the use of psilocybin mushrooms for therapeutic treatment. Before this, these substances were strictly restricted, but a growing body of studies suggests they may offer relief for mental health illnesses like anxiety. This development represents a substantial step